Environmentally responsive peptides as anticancer drug carriers

被引:108
作者
Aluri, Suhaas [1 ]
Janib, Siti M. [1 ]
Mackay, J. Andrew [1 ]
机构
[1] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90033 USA
关键词
EPR; Tumor; Hyperthermia; Peptides; Drug delivery; Redox; Cancer; pH; Chemotherapy; RECEPTOR-MEDIATED ENDOCYTOSIS; ELASTIN-LIKE POLYPEPTIDE; PH-SENSITIVE LIPOSOMES; HUMAN TUMOR XENOGRAFT; IN-VIVO; TARGETED DELIVERY; CARBOXYMETHYL POLY(L-HISTIDINE); INTRACELLULAR DELIVERY; DOXORUBICIN CONJUGATE; GELATIN NANOPARTICLES;
D O I
10.1016/j.addr.2009.07.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The tumor microenvironment provides multiple cues that may be exploited to improve the efficacy of established chemotherapeutics; furthermore, polypeptides are uniquely situated to capitalize on these signals. Peptides provide: 1) a rich repertoire of biologically specific interactions to draw upon: 2) environmentally responsive phase behaviors, which may be tuned to respond to signatures of disease; 3) opportunities to direct self-assembly: 4) control over routes of biodegradation; 5) the option to seamlessly combine functionalities into a single polymer via a one-step biosynthesis. As development of cancer-targeted nanocarriers expands, peptides provide a unique source of functional units that may target disease. This review explores potential microenvironmental physiology indicative of tumors and peptides that have demonstrated an ability to target and deliver to these signals. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:940 / 952
页数:13
相关论文
共 154 条
[41]   X-RAY-DIFFRACTION DEMONSTRATES THAT PHOSPHATIDYLDIACYLGLYCEROL AND PHOSPHATIDYLCHOLESTEROL ARE NOT LAMELLAR ABOVE THE MAIN TRANSITION-TEMPERATURE [J].
GRUNER, SM ;
JAIN, MK .
BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 818 (03) :352-355
[42]   Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications [J].
Gupta, Ajay Kumar ;
Naregalkar, Rohan R. ;
Vaidya, Vikas Deep ;
Gupta, Mona .
NANOMEDICINE, 2007, 2 (01) :23-39
[43]   Design of a pH-sensitive pore-forming peptide with improved performance [J].
Haas, DH ;
Murphy, RM .
JOURNAL OF PEPTIDE RESEARCH, 2004, 63 (01) :9-16
[44]   Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia [J].
Hamann, PR ;
Hinman, LM ;
Hollander, I ;
Beyer, CF ;
Lindh, D ;
Holcomb, R ;
Hallett, W ;
Tsou, HR ;
Upeslacis, J ;
Shochat, D ;
Mountain, A ;
Flowers, DA ;
Bernstein, I .
BIOCONJUGATE CHEMISTRY, 2002, 13 (01) :47-58
[45]   Hyperthermia-induced antitumor activity of thermosensitive polymer modified temperature-sensitive liposomes [J].
Han, Hee Dong ;
Choi, Min Soo ;
Hwang, Taewon ;
Song, Chung Kil ;
Seong, Hasoo ;
Kim, Tae Woo ;
Choi, Ho Suk ;
Shin, Byung Cheol .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (09) :1909-1917
[46]   Intracellular delivery of nanocarriers for cancer therapy [J].
Har-el, Yah-el ;
Kato, Yoshinori .
CURRENT NANOSCIENCE, 2007, 3 (04) :329-338
[47]   X-ray diffraction structures of some phosphatidylethanolamine lamellar and inverted hexagonal phases [J].
Harper, PE ;
Mannock, DA ;
Lewis, RNAH ;
McElhaney, RN ;
Gruner, SM .
BIOPHYSICAL JOURNAL, 2001, 81 (05) :2693-2706
[48]   Thermally associating polypeptides designed for drug delivery produced by genetically engineered cells [J].
Hart, David S. ;
Gehrke, Stevin H. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (03) :484-516
[49]   DETERMINATION OF GLUTATHIONE AND GLUTATHIONE-REDUCTASE WITH A SILVER SULFIDE MEMBRANE-ELECTRODE [J].
HASSAN, SSM ;
RECHNITZ, GA .
ANALYTICAL CHEMISTRY, 1982, 54 (12) :1972-1976
[50]   Protein nanoparticles as drug carriers in clinical medicine [J].
Hawkins, Michael J. ;
Soon-Shiong, Patrick ;
Desai, Neil .
ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (08) :876-885